$10 Billion Deal, page-7565

Yes I believe that is correct wrt compound testing?
But BIT225 is part of the HIV trials, if they find that BIT225 is the most active of those compounds then there is nothing stopping Biotron taking the HIV treatment to Phase three, BIT225 has been used in humans in those trials, and if the HIV trial in Phase 3 was successful, that drug can then be registered, I would bet that they could then use it off label, I believe this would be the quickest path for BIT225 to counter Covid19, they could then continue with human trials for Covid19 I reckon with all of the other compounds which may be an even better drug to fight Covid19.